The aim of the current study was to evaluate a newly developed electrochemiluminescence (ECL)-GAD antibody (GADA) assay and compare its sensitivity and disease relevance with standard radioassay.
Gene fusions are vital biomarkers for tumor diagnosis and drug development, with precise detection becoming increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback